Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 1998 December;133(6) > Giornale Italiano di Dermatologia e Venereologia 1998 December;133(6):399-404

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

ORIGINAL ARTICLES  


Giornale Italiano di Dermatologia e Venereologia 1998 December;133(6):399-404

Copyright © 1998 EDIZIONI MINERVA MEDICA

language: English

Postoperative radiotherapy of earlobe keloids

Caccialanza M. 1, Dal Pozzo V. 2, Piccinno R. 1, Beretta M. 1, Gnecchi L. 1

1 From the Department of Photoradiotherapy, Ospedale Maggiore, IRCCS, Milan, University of Milan; 2 Dermatological Surgery, Institute of Dermatological Sciences, Ospedale Maggiore, IRCCS, Milan University of Milan


PDF  


Background. Earlobe ­keloids are ­very fre­quent and ­often char­ac­ter­ized by a peculiar clin­i­cal beha­vi­our and ­response to the­rapy. They, rep­re­sent a cos­met­ic prob­lem, and may ­often ­cause ­pain to the ­patient as ­well. Aim of ­this ­study was to ­assess, ­through a ret­ro­spec­tive ­study of our cas­es, the effec­tive­ness and safe­ty of post­op­er­a­tive radio­ther­a­py per­formed in the peri­od 1983-1996.
Methods. Seventeen ­patients affect­ed by 20 ­keloid ­lesions ­were includ­ed in ­this ­study. Each ­lesion was his­to­log­i­cal­ly ascer­tained. Twelve ­were relaps­ing ­after pre­vi­ous non-radio­log­i­cal ther­a­pies. In 15 out of 17 cas­es radio­ther­a­py was ­begun 7 ­days ­after sur­gery and per­formed ­with con­tact X-ray ther­a­py (Chaoul). The ­total dos­es admin­is­tered ­ranged ­from 20 to 30 Gy, by ­means of week­ly frac­tions of 5 Gy ­each.
Results. The ­mean fol­low-up of the stud­ied ­patient ­series was 64 ­months (­range 7-146 ­months). Complete remis­sion was ­obtained in the ­whole ­series (two ­lesions ­relapsed, but a new remis­sion was ­obtained in one by ­means of cor­ti­cos­ter­oid injec­tions and in the oth­er by ­means of a new sur­gi­cal exci­sion fol­lowed by post­op­er­a­tive radio­ther­a­py). The twen­ty-­four ­month ­relapse-­free ­rate ­after radio­ther­a­py was 83.36%. The cos­met­ic ­results ­were ­judged as ­good in all cas­es. No com­pli­ca­tions and/or seque­lae relat­ed to post­op­er­a­tive radio­ther­a­py ­were ­observed.
Conclusions. The ­results ­obtained sup­port ­that post­op­er­a­tive radio­ther­a­py per­formed by ­means of ­skin dis­eas­es ded­i­cat­ed ­machines and ­with an inte­grate sur­gi­cal-radio­the­rap­ic ­approach is an effec­tive and ­safe treat­ment.

top of page

Publication History

Cite this article as

Corresponding author e-mail